Cargando…
Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand
BACKGROUND: Zidovudine (ZDV) has been associated with risk of haematological toxicity. Safety data from clinical trials is generally limited to 48 weeks. We assessed the short- and mid-term toxicity of ZDV/lamivudine (3TC) fixed-dose combination scored tablets in HIV-infected children followed in th...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350228/ https://www.ncbi.nlm.nih.gov/pubmed/28028587 http://dx.doi.org/10.1007/s00228-016-2182-2 |